All In Biotech

Drug Trial Radar · NCT03320070

Acthar Gel in Participants With Pulmonary Sarcoidosis

A Multicenter, Randomized, Double Blind, Placebo Controlled Exploratory Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Pulmonary Sarcoidosis

Last checked: Nov 20, 2026Latest source record: Feb 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

55

Actual

Start

Feb 21, 2018

Primary completion

Nov 15, 2021

Study completion Nov 15, 2021

Sponsor

Lead sponsor
MallinckrodtIndustry
Sponsor type
Industry
First posted
Oct 25, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find out if Acthar Gel is safe and effective to treat pulmonary sarcoidosis. Participants will be randomly assigned (like flipping a coin) to receive a shot under their skin of Acthar Gel or a matching placebo gel that has no drug in it. They will receive their assigned shot twice a week for 24 weeks. All participants who complete the 24-week treatment period will be eligible to receive Acthar Gel for 24 more weeks, even if they were originally in the placebo group.

Conditions

  • Sarcoidosis, Pulmonary

Interventions

  • Acthar GelDrug

    Acthar Gel for subcutaneous (SC) injection (80 units per 1 mL)

  • PlaceboDrug

    Placebo gel for SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. DBT: Number of Participants in Each Category of Assessment Based on Forced Vital Capacity (FVC), a Pulmonary Function Test Parameter at Week 24Time frame: Week 24
  2. OLE: Number of Participants in Each Category of Assessment Based on FVC, a Pulmonary Function Test Parameter at Week 48Time frame: Week 48
  3. DBT: Number of Participants in Each Category of Assessment Based on the Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO), a Pulmonary Function Test Parameter at Week 24Time frame: Week 24
  4. OLE: Number of Participants in Each Category of Assessment Based on the DLCO, a Pulmonary Function Test Parameter at Week 48Time frame: Week 48
  5. DBT: Number of Participants in Each Category of Assessment Based on High Resolution Computer Tomography (HRCT) at Week 24Time frame: Week 24
  6. OLE: Number of Participants in Each Category of Assessment Based on HRCT at Week 48Time frame: Week 48
  7. DBT: Number of Participants in Each Category of Assessment Based on the King's Sarcoidosis Questionnaire (KSQ) (General Health), a Quality of Life Parameter at Week 24Time frame: Week 24
  8. OLE: Number of Participants in Each Category of Assessment Based on the KSQ (General Health), a Quality of Life Parameter at Week 48Time frame: Week 48
  9. DBT: Number of Participants in Each Category of Assessment Based on the Fatigue Assessment Score (FAS), a Quality of Life Parameter at Week 24Time frame: Week 24
  10. OLE: Number of Participants in Each Category of Assessment Based on FAS, a Quality of Life Parameter at Week 48Time frame: Week 48
  11. DBT: Number of Participants in Each Category of Assessment Based on Corticosteroid Taper Score in Participants Receiving Each Dose of Prednisone at Week 24Time frame: Week 24
  12. OLE: Number of Participants in Each Category of Assessment Based on Corticosteroid Taper Score in Participants Receiving Each Dose of Prednisone at Week 48Time frame: Week 48

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • UAB Lung Health Center

    Birmingham, Alabama

  • David Geffen School of Medicine

    Los Angeles, California

  • National Jewish Health

    Denver, Colorado

  • University of Florida Division of Pulmonary, Critical Care, and Sleep Medicine

    Gainesville, Florida

  • University of Miami Miller School of Medicine

    Miami, Florida

  • Central Florida Pulmonary Group PA

    Orlando, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • Laporte County Institute For Clinical Research

    Michigan City, Indiana

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Howard County Center for Lung and Sleep Medicine, LLC

    Columbia, Maryland

  • Washington University School of Medicine

    St Louis, Missouri

  • Valley Medical Group

    Ridgewood, New Jersey

  • Albany Medical Center

    Albany, New York

  • American Health Research Inc

    Charlotte, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • Clinical Research of Gastonia

    Gastonia, North Carolina

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • Penn State Milton S Hershey Medical Center

    Hershey, Pennsylvania

  • Temple Lung Center

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Berks Schuylkill Respiratory Specialists, Ltd

    Wyomissing, Pennsylvania

  • VitaLink Research - Anderson

    Anderson, South Carolina

  • Medical University of South Carolina - PPDS

    Charleston, South Carolina

  • Clinical Research of Charleston

    Mt. Pleasant, South Carolina

  • Clinical Research of Rock Hill

    Rock Hill, South Carolina

  • VitaLink Research - Spartanburg

    Spartanburg, South Carolina

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • University of Texas Health Science Center at Tyler

    Tyler, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.